In Alzheimer’s disease, the receptor for advanced glycation end products (RAGE) expressed in BMECs mediates the transport of the neurotoxic amyloid-β peptide from the blood into the brain, leading to oxidative stress and neuroinflammation26. The gene discussed is AGER; the disease is early-onset autosomal dominant Alzheimer disease.